Citi Starts Ascendis Pharma (ASND) at Buy
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $246.23 --0%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
Citi analyst David Lebowitz initiates coverage on Ascendis Pharma (NASDAQ: ASND) with a Buy rating and a price target of $187.00.
For an analyst ratings summary and ratings history on Ascendis Pharma click here. For more ratings news on Ascendis Pharma click here.
Shares of Ascendis Pharma closed at $108.52 yesterday.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Lowered to $329 at Barclays
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
